1. Home
  2. VOXR vs XOMA Comparison

VOXR vs XOMA Comparison

Compare VOXR & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vox Royalty Corp.

VOXR

Vox Royalty Corp.

HOLD

Current Price

$6.14

Market Cap

362.5M

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$26.63

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VOXR
XOMA
Founded
2014
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
362.5M
308.6M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
VOXR
XOMA
Price
$6.14
$26.63
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$60.60
AVG Volume (30 Days)
760.7K
235.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.86%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$44.95
$77.29
Revenue Next Year
$89.38
$29.30
P/E Ratio
N/A
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$2.29
$18.40
52 Week High
$5.94
$39.92

Technical Indicators

Market Signals
Indicator
VOXR
XOMA
Relative Strength Index (RSI) 66.10 53.59
Support Level $4.86 $23.71
Resistance Level N/A $27.73
Average True Range (ATR) 0.30 1.28
MACD 0.07 0.38
Stochastic Oscillator 97.65 79.08

Price Performance

Historical Comparison
VOXR
XOMA

About VOXR Vox Royalty Corp.

Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: